Solid Biosciences Inc. SLDB Net investment gains (losses)
Net investment gains (losses) at other companies
Other financials
Where this comes from
Reported directly by Solid Biosciences Inc. in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnDerivativeInstrumentsNetPretax.
The official record: Solid Biosciences Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Solid Biosciences Inc.'s net investment gains (losses).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Solid Biosciences Inc.'s net investment gains (losses)?
- Solid Biosciences Inc. (SLDB) reported net investment gains (losses) of -$1.65M in Q1 2026.
- How has Solid Biosciences Inc.'s net investment gains (losses) changed year-over-year?
- Solid Biosciences Inc.'s net investment gains (losses) decreased by 0.0% year-over-year, from -$1.65M to -$1.65M.
- What does net investment gains (losses) mean?
- Net realized and unrealized gains and losses on the company's investment portfolio, including equity securities, debt securities, and alternative investments.